Indian firms get FDA approval for 110 generic drugs
Indian drugmakers have gained more than 100 generic drug approvals from the FDA this year so far, taking its share in US approvals to nearly 40 percent, as reported Business Standard Sunday.
In 2013, the FDA approved nearly 290 drugs, with at least 110 of these applications from Indian companies.
Indian companies include entities belonging to Sun Pharma, Lupin, Aurobindo Pharma, Zydus, Glenmark, Dr Reddy’s, Emcure, Wockhardt, Torrent, Claris, Alkem, Ipca, Cipla, Famy Care, Natco, Hetero and Alembic.
In 2012, India shipped pharmaceutical products worth over $4 billion to the US, indicating a growth of around 30 percent from the previous year.
Lupin was reportedly the lead Indian drug seller in the US market last year by prescriptions.